Clinical Trials Logo

Impulse Control Disorders clinical trials

View clinical trials related to Impulse Control Disorders.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03887429 Completed - Clinical trials for Impulse Control Disorders

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

Start date: March 4, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to explore the safety, tolerability and activity of SXC-2023 or placebo when dosed for 5 days in adults with tobacco use disorder who voluntarily abstain from the use of cigarettes.

NCT ID: NCT02755181 Completed - Clinical trials for Borderline Personality Disorder

fMRI in Impulsivity

Start date: July 22, 2016
Phase:
Study type: Observational

This study aims to use resting-state and task based functional Magnetic Resonance Imaging (fMRI) as a tool to evaluate trait characteristics of impulsivity in subjects with borderline personality disorder.

NCT ID: NCT02733562 Completed - Obesity Clinical Trials

Results of Sleeve Gastrectomy Surgery in Relation With Eating Habits (After One Year)

Behavior
Start date: January 2014
Phase: N/A
Study type: Observational

Sleeve gastrectomy is one of the most common surgical procedures performed today for patients that undergo bariatric surgery. One of the primary reasons for morbid obesity is unhealthy eating habits and the belief that changes in those habits can ensure the success. Objectives: The investigators aimed to explore the effect of different eating habits prior to the bariatric surgery on the surgery success and on different aspect of quality of life. Design: The investigators conducted this study on patients that underwent sleeve gastrectomy as the first bariatric operation.

NCT ID: NCT02722174 Completed - Clinical trials for Impulse Control Disorders

Fingerprinting of Impulsivity

Start date: July 22, 2016
Phase:
Study type: Observational

The study aims to examine a battery of behavioral and questionnaire measures in 4 disorders clinically associated with impulsivity and in health controls, to: 1) investigate if the different populations have a distinct behavioral profile, and 2) to investigate if there are specific measures that are reliable and sensitive measures of impulsivity across diagnoses.

NCT ID: NCT02319395 Completed - Parkinson Disease Clinical Trials

Behavioural Addiction and Genetics in Parkinson's Disease

BADGE-PD
Start date: November 2011
Phase: N/A
Study type: Observational

The " Behavioural Addiction and Genetics in Parkinson's Disease " study (BADGE-PD) is a national (France), multicenter, genetic association, case-control study to identify genetic factors associated with behavioural addiction (or Impulse Control Disorders, ICD) related to dopamine agonists treatment in Parkinson's disease (PD). Polymorphisms of candidate genes supposed to be involved in this adverse effect will be compared in 200 PD patients with ICD (n=200) and 200 matched PD patients without ICD (n=200).

NCT ID: NCT01052831 Completed - Parkinson Disease Clinical Trials

Naltrexone for Impulse Control Disorders in Parkinson's Disease

Start date: November 2009
Phase: Phase 4
Study type: Interventional

This study will evaluate the effectiveness of naltrexone in reducing ICD symptoms in Parkinson's disease patients taking a dopamine agonist.

NCT ID: NCT00667212 Completed - Anger Clinical Trials

Psychotherapy for Intermittent Explosive Disorder

Start date: August 2006
Phase: Phase 2
Study type: Interventional

The goal of this study is to examine the effectiveness two forms of psychotherapy (also known as "talk therapy" ) for individuals with anger and aggression problems. Anger and aggression are everywhere - on the road, in the schools, at little league games, at home, and at work. In this study we are testing usefulness of anger management techniques in reducing symptoms of Intermittent Explosive Disorder (IED) and impulsive, aggressive behavior.

NCT ID: NCT00617019 Completed - Parkinson Disease Clinical Trials

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Start date: September 2006
Phase: N/A
Study type: Observational

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

NCT ID: NCT00399698 Completed - Bipolar Disorder Clinical Trials

Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.

Start date: May 1999
Phase: Phase 3
Study type: Interventional

This study was developed in order to assess the effects of risperidone (Risperdal) as compared with placebo on cognitive-motor performance (attention, memory, and hand steadiness) and body movements. We propose to study the effects of risperidone on cognitive-motor performance in children already medicated for severe conduct problems. We would also like to look at safety by assessing these children for dyskinetic movements. We already have a sizable cohort of children maintained on risperidone. Our hypotheses are as follows: 1. Risperidone will have no adverse effects on cognitive-motor performance in children who have received maintenance therapy for 4 to 20 months. 2. Children tested during placebo will show no more dyskinetic movements than during risperidone treatment (i.e., there will be no unmasking of tardive dyskinesia).

NCT ID: NCT00127400 Completed - Anger Clinical Trials

A Pilot Study Comparing the Efficacy of Group Versus Individual Anger Management in Subjects With IED

Start date: February 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to see how different forms of "Anger Management" compare in reducing anger and impulsive aggressive symptoms in people. "Anger Management" is a common form of "talk therapy" used to help people with anger problems. There are different types of "talk therapy" used to help people for anger problems and this study will compare two types of talk therapy in people with Intermittent Explosive Disorder (IED). IED is a disorder in which there are frequent and sudden outbursts of anger (yelling, throwing and breaking things, hitting people) that lead to problems with other people socially or at work.